Stockreport

Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Vaxcyte, Inc.  (PCVX) 
PDF SAN CARLOS, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to p [Read more]